Conferences

CONFERENCE

AMP 2020 Virtual Meeting & Expo

November 16 - 20, 2020, Virtual

Read More

November 16-20th – Join us for this year’s Association for Molecular Pathology (AMP) Virtual Education and Networking Experience. Watch the Corporate Workshop on-demand here

News & Press

BLOG By Martin Reese & Laura Yecies By Martin Reese & Laura Yecies DOWNLOAD AS A PDF It was terrific to see this paper by our long time collaborator Arindam Bhattacharjeeon the use of NGS as a second-tier test for Pompe Disease (PD). This is part of an important diagnostic trend of earlier (even to …

Read More

Fabric Genomics speeds and scales genomic interpretation by combining the most advanced AI algorithms with automated workflows, while Genomenon®’s literature search engine facilitates comprehensive literature review, which is advantageous for accurate interpretation. The companies have entered into an agreement to integrate and co-market their solutions, announced today during the American Society of Human Genetics conference …

Read More

BLOG Featured XIFIN, Inc. Blog By Laura Yecies Next-Generation Sequencing (NGS) testing is experiencing tremendous growth driven at a high level by the promise of precision medicine and the life-changing power of applications in preventive genetic screening, somatic testing, and rare disease diagnosis. In all of these use cases, we see important clinical advances. Preventive …

Read More

In a step toward the full realization of genomic medicine, Fabric Genomics, a leader in AI-based genomic analysis and interpretation, has announced a co-marketing agreement that will provide translational researchers around the world with integrated sample prep to reporting workflows. Combining Roche’s newly released KAPA HyperExome Probes (RUO) with the Fabric Enterprise bioinformatics and analysis …

Read More

Fabric Genomics, a global leader in clinical interpretation of genomic data, announced today the launch of Fabric GEM, a novel algorithm that quickly and efficiently identifies the likely genetic cause of rare diseases from next-generation sequencing data – enabling faster diagnosis and the possibility of faster and more effective treatment.

Read More
BLOG | August 13, 2020

BLOG By Martin Reese & Laura Yecies When caring for a critically ill child, two simultaneous thoughts are competing – the urgent need for a diagnosis to optimize treatment and the need for thoroughness – to carefully review all the possibilities.  Don’t jump to a conclusion but don’t get lost in the weeds keeping the …

Read More

BLOG By Charlene Son Rigby & Brent Lutz By Martin Reese & Laura Yecies DOWNLOAD AS A PDF DOWNLOAD AS A PDF The validation process for laboratory-developed tests (LDTs) can vary dramatically depending on the type of assay you wish to validate and can appear complicated and overwhelming to beginners. In this post, we provide …

Read More

BLOG By Charlene Son Rigby & Brent Lutz By Martin Reese & Laura Yecies DOWNLOAD AS A PDF Increasingly, diagnostic laboratories are turning to next-generation sequencing (NGS) to detect heritable pathogenic mutations and somatic mutations that help to characterize and identify appropriate cancer treatments. As with any lab-developed test (LDT), NGS tests need to be …

Read More

BLOG A Case Study of Project Baby Bear at Rady Children’s Hospital-San Diego By Martin Reese & Laura Yecies The power and cost-effectiveness of AI are calling into question many of our assumptions about healthcare.  The most important dichotomy proving to be false is that providing the latest and most thorough diagnostic technology to optimize …

Read More

BLOG By Charlene Son Rigby By Martin Reese & Laura Yecies Genomics provides the opportunity to realize the promise of personalized medicine, with tests scaling from single genes to comprehensive panels, exomes and whole genomes. Whole genome and whole exome sequencing provide a wealth of information to potentially identify the cause of disease in an …

Read More

In this webinar, Francisco De La Vega will introduce the Fabric GEM AI algorithm and demonstrate how it significantly simplifies and improves disease-causing variant identification over prior methods, substantially reducing genome interpretation time in the diagnosis of monogenic disease, and could allow cost-effective, automated reanalysis of undiagnosed cases over time. 

Read More

Labs from every sector- private, reference, hospital, and academic- may be considering expansion of their test offering to include next generation sequencing (NGS). However, before implementing NGS, there are a number of factors that lab leaders must carefully consider to ensure that successful implementation and sustainability of their NGS program. Join XIFIN and Fabric Genomics …

Read More

Clinical genomic testing and next-generation sequencing (NGS) are integral parts of realizing the potential of precision medicine, but the data complexity and technical integrations needed to make genomic data clinically meaningful and routinized have slowed mainstream adoption of these breakthrough technologies. Today, Fabric Genomics, a global leader in clinical interpretation of genomic data, announced a distribution agreement with XIFIN, a …

Read More

Researchers at Rady Children’s Institute for Genomic Medicine (RCIGM) and its partners, including Fabric Genomics, have today published in Science Translational Medicine a new study documenting the process to diagnose rare genetic diseases in record time. This new method speeds answers to physicians and allows increased use of genome sequencing as a first-line diagnostic test …

Read More

Fabric Genomics will launch a new solution this week for variant interpretation and clinical reporting, allowing clinical laboratories to dramatically accelerate turnaround times. This new software solution, called Fabric Hereditary Panels with ACE (AI Classification Engine), will debut at the ACMG annual meeting in Seattle, Washington. The solution incorporates an extensively validated, automated ACMG classification …

Read More

In this presentation by Fabric Genomics, Dr. Katarzyna (Kasia) Ellsworth, Associate Laboratory Director at Rady Children’s Institute for Genomic Medicine, discusses the launching and scaling clinical NGS testing in a children’s hospital environment, utilizing Fabric Enterprise for the rapid interpretation of genomic data to decrease turnaround time and increase diagnostic yield. Rady is advancing rapid …

Read More